The candidate immunotherapeutical target, the receptor for hyaluronic acid-mediated motility, is associated with proliferation and shows prognostic value in B-cell chronic lymphocytic leukemia

Erstveröffentlichung

2009

Authors

Giannopoulos, K.

Mertens, D.

Buehler, A.

Barth, T. F. E.

Idler, I.

et al.

Wissenschaftlicher Artikel

Published in

Leukemia ; 23 (2009), 3. - S. 519-527. - ISSN 0887-6924

Link to publication

https://dx.doi.org/10.1038/leu.2008.338

Institutions

UKU. Klinik für Innere Medizin III
UKU. Institut für Pathologie

Subject headings

[Free subject headings]: B-cell chronic lymphocytic leukemia (B-CLL) | tumor-associated antigens (TAAs) | cytotoxic T lymphocytes (CTL) | receptor for hyaluronic acid mediated motility (RHAMM/CD168) | tumor-associated antigens | acute myeloid-leukemia | multiple-myeloma | mutation status | soluble cd44 | high-risk | expression | rhamm | disease | protein
[DDC subject group]: DDC 610 / Medicine & health

Metadata

Show full item record